Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India

Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India

Glenmark Pharmaceuticals and Canadian pharma company SaNOtize Research & Development Corp. have launched the latter’s Nitric Oxide Nasal Spray under the brand name FabiSpray in India for the treatment of adults with Covid-19, who have a high risk of disease progression Earlier, Glenmark Pharmaceuticals had secured manufacturing and marketing approval from the Drugs Controller General […]

Glenmark gets marketing approval for Ryaltris in 13 European countries

Glenmark gets marketing approval for Ryaltris in 13 European countries

Glenmark Pharmaceuticals said that it has secured marketing approval for Ryaltris, a fixed-dose combination nasal spray, in 13 countries across the European Union (EU) and the UK. Ryaltris (olopatadine 665 µg and mometasone furoate 25 µg) has approval for the symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children, aged over 12. […]